| A review of stimuli-responsive nanocarriers for drug and gene delivery S Ganta, H Devalapally, A Shahiwala, M Amiji Journal of controlled release 126 (3), 187-204, 2008 | 2479 | 2008 |
| Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells S Ganta, M Amiji Molecular pharmaceutics 6 (3), 928-939, 2009 | 583 | 2009 |
| Role of integrated cancer nanomedicine in overcoming drug resistance AK Iyer, A Singh, S Ganta, MM Amiji Advanced drug delivery reviews 65 (13-14), 1784-1802, 2013 | 362 | 2013 |
| Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields M Chorny, I Fishbein, BB Yellen, IS Alferiev, M Bakay, S Ganta, R Adamo, ... Proceedings of the National Academy of Sciences 107 (18), 8346-8351, 2010 | 248 | 2010 |
| Nanoemulsions in translational research—opportunities and challenges in targeted cancer therapy S Ganta, M Talekar, A Singh, TP Coleman, MM Amiji Aaps Pharmscitech 15, 694-708, 2014 | 238 | 2014 |
| Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation S Ganta, H Devalapally, M Amiji Journal of pharmaceutical sciences 99 (11), 4630-4641, 2010 | 157 | 2010 |
| Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery S Ganta, JW Paxton, BC Baguley, S Garg International Journal of Pharmaceutics 367 (1-2), 179-186, 2009 | 146 | 2009 |
| Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery SC Abeylath, S Ganta, AK Iyer, M Amiji Accounts of chemical research 44 (10), 1009-1017, 2011 | 133 | 2011 |
| A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers S Ganta, D Deshpande, A Korde, M Amiji Molecular membrane biology 27 (7), 260-273, 2010 | 106 | 2010 |
| Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice CA Dehelean, S Feflea, D Gheorgheosu, S Ganta, AM Cimpean, ... Journal of biomedical nanotechnology 9 (4), 577-589, 2013 | 93 | 2013 |
| Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay CA Dehelean, S Feflea, S Ganta, M Amiji Journal of biomedical nanotechnology 7 (2), 317-324, 2011 | 88 | 2011 |
| Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion S Ganta, JW Paxton, BC Baguley, S Garg International journal of pharmaceutics 360 (1-2), 115-121, 2008 | 88 | 2008 |
| Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer S Ganta, A Singh, Y Rawal, J Cacaccio, NR Patel, P Kulkarni, CF Ferris, ... Drug delivery 23 (3), 958-970, 2016 | 77 | 2016 |
| Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil P Sharma, S Ganta, WA Denny, S Garg International journal of pharmaceutics 367 (1-2), 187-194, 2009 | 69 | 2009 |
| Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion S Ganta, P Sharma, JW Paxton, BC Baguley, S Garg Journal of drug targeting 18 (2), 125-133, 2010 | 58 | 2010 |
| Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer S Ganta, A Singh, NR Patel, J Cacaccio, YH Rawal, BJ Davis, MM Amiji, ... Pharmaceutical research 31, 2490-2502, 2014 | 56 | 2014 |
| In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers NR Patel, A Piroyan, S Ganta, AB Morse, KM Candiloro, AL Solon, ... Cancer biology & therapy 19 (7), 554-564, 2018 | 45 | 2018 |
| EGFR targeted theranostic nanoemulsion for image-guided ovarian cancer therapy S Ganta, A Singh, P Kulkarni, AW Keeler, A Piroyan, RR Sawant, ... Pharmaceutical research 32, 2753-2763, 2015 | 45 | 2015 |
| Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian … M Talekar, S Ganta, A Singh, M Amiji, J Kendall, WA Denny, S Garg Pharmaceutical research 29, 2874-2886, 2012 | 45 | 2012 |
| Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy M Talekar, S Ganta, M Amiji, S Jamieson, J Kendall, WA Denny, S Garg International journal of pharmaceutics 450 (1-2), 278-289, 2013 | 41 | 2013 |
